93 related articles for article (PubMed ID: 26984955)
1. COX-2 gene dosage-dependent defects in kidney development.
Slattery P; Frölich S; Schreiber Y; Nüsing RM
Am J Physiol Renal Physiol; 2016 May; 310(10):F1113-22. PubMed ID: 26984955
[TBL] [Abstract][Full Text] [Related]
2. Salt supplementation ameliorates developmental kidney defects in COX-2
Slattery P; Frölich S; Goren I; Nüsing RM
Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1044-F1055. PubMed ID: 28274925
[TBL] [Abstract][Full Text] [Related]
3. Temporal expression of the PGE2 synthetic system in the kidney is associated with the time frame of renal developmental vulnerability to cyclooxygenase-2 inhibition.
Frölich S; Olliges A; Kern N; Schreiber Y; Narumiya S; Nüsing RM
Am J Physiol Renal Physiol; 2012 Jul; 303(2):F209-19. PubMed ID: 22573380
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II-AT1-receptor signaling is necessary for cyclooxygenase-2-dependent postnatal nephron generation.
Frölich S; Slattery P; Thomas D; Goren I; Ferreiros N; Jensen BL; Nüsing RM
Kidney Int; 2017 Apr; 91(4):818-829. PubMed ID: 28040266
[TBL] [Abstract][Full Text] [Related]
5. Defects in mouse nephrogenesis induced by selective and non-selective cyclooxygenase-2 inhibitors.
Olliges A; Wimmer S; Nüsing RM
Br J Pharmacol; 2011 Jul; 163(5):927-36. PubMed ID: 21391980
[TBL] [Abstract][Full Text] [Related]
6. Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice.
Norwood VF; Morham SG; Smithies O
Kidney Int; 2000 Dec; 58(6):2291-300. PubMed ID: 11115063
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development.
Kömhoff M; Wang JL; Cheng HF; Langenbach R; McKanna JA; Harris RC; Breyer MD
Kidney Int; 2000 Feb; 57(2):414-22. PubMed ID: 10652018
[TBL] [Abstract][Full Text] [Related]
8. COX-2 activity determines the level of renin expression but is dispensable for acute upregulation of renin expression in rat kidneys.
Matzdorf C; Kurtz A; Höcherl K
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1782-90. PubMed ID: 17376760
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites.
López-Parra M; Clària J; Planagumà A; Titos E; Masferrer JL; Woerner BM; Koki AT; Jiménez W; Altuna R; Arroyo V; Rivera F; Rodés J
Br J Pharmacol; 2002 Feb; 135(4):891-900. PubMed ID: 11861316
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension.
Zhang MZ; Yao B; Wang Y; Yang S; Wang S; Fan X; Harris RC
J Clin Invest; 2015 Nov; 125(11):4281-94. PubMed ID: 26485285
[TBL] [Abstract][Full Text] [Related]
11. Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor.
Horrillo R; Planagumà A; González-Périz A; Ferré N; Titos E; Miquel R; López-Parra M; Masferrer JL; Arroyo V; Clària J
J Pharmacol Exp Ther; 2007 Dec; 323(3):778-86. PubMed ID: 17766677
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta.
Qi Z; Cai H; Morrow JD; Breyer MD
Hypertension; 2006 Aug; 48(2):323-8. PubMed ID: 16801485
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with paricalcitol attenuates inflammation in ischemia-reperfusion injury via the up-regulation of cyclooxygenase-2 and prostaglandin E2.
Hwang HS; Yang KJ; Park KC; Choi HS; Kim SH; Hong SY; Jeon BH; Chang YK; Park CW; Kim SY; Lee SJ; Yang CW
Nephrol Dial Transplant; 2013 May; 28(5):1156-66. PubMed ID: 23229926
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib offsets the negative renal influences of cyclosporine via modulation of the TGF-β1/IL-2/COX-2/endothelin ET(B) receptor cascade.
El-Gowelli HM; Helmy MW; Ali RM; El-Mas MM
Toxicol Appl Pharmacol; 2014 Mar; 275(2):88-95. PubMed ID: 24462674
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney.
Fujihara CK; Antunes GR; Mattar AL; Andreoli N; Malheiros DM; Noronha IL; Zatz R
Kidney Int; 2003 Dec; 64(6):2172-81. PubMed ID: 14633140
[TBL] [Abstract][Full Text] [Related]
16. Effect of maternal administration of selective cyclooxygenase (COX)-2 inhibitors on renal size, growth factors, proteinases, and COX-2 secretion in the fetal rabbit.
Hartleroad JY; Beharry KD; Hausman N; Stavitsky Y; Asrat T; Modanlou HD
Biol Neonate; 2005; 87(4):246-53. PubMed ID: 15668523
[TBL] [Abstract][Full Text] [Related]
17. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
18. Renal localization and regulation of 15-hydroxyprostaglandin dehydrogenase.
Yao B; Xu J; Harris RC; Zhang MZ
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F433-9. PubMed ID: 18057186
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of chronic kidney disease in dogs and cats: induction of cyclooxygenases.
Yabuki A; Mitani S; Sawa M; Mizukami K; Fujiki M; Yamato O
Res Vet Sci; 2012 Oct; 93(2):892-7. PubMed ID: 22244709
[TBL] [Abstract][Full Text] [Related]
20. Puromycin induces reversible proteinuric injury in transgenic mice expressing cyclooxygenase-2 in podocytes.
Jo YI; Cheng H; Wang S; Moeckel GW; Harris RC
Nephron Exp Nephrol; 2007; 107(3):e87-94. PubMed ID: 17890881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
